Scancell is a clinical stage immunotherapy biotech company developing treatments for unmet needs in cancer. The company focuses on creating responses in patients while prioritizing safety, specifically targeting hard-to-treat cancers.
EptivA Therapeutics is transforming the way pain is treated with its innovative Personalized Analgesics® approach.
Company Details
Scancell is operated by Scancell Holdings Plc and is a Active company incorporated on 14 April 2008 with the registered office located in Oxford, Oxfordshire. Scancell Holdings Plc was registered 17 years ago.